Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al

被引：3
|
作者：
Wahl, Denis [1 ,2 ]
Lecompte, Thomas [1 ,2 ]
Bounameaux, Henri [3 ]
机构：
[1] Nancy Univ Hosp, Vandoeuvre Les Nancy, France
[2] INSERM, U734, F-54511 Vandoeuvre Les Nancy, France
[3] Univ Hosp Geneva, Geneva, Switzerland
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 02期
关键词：
D O I：
10.1002/art.23160
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：635 / 636
页数：2
相关论文
共 50 条
  • [21] Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study
    Ruffatti, Amelia
    Tonello, Marta
    Hoxha, Ariela
    Sciascia, Savino
    Cuadrado, Maria J.
    Latino, Jose O.
    Udry, Sebastian
    Reshetnyak, Tatiana
    Costedoat-Chalumeau, Nathalie
    Morel, Nathalie
    Marozio, Luca
    Tincani, Angela
    Andreoli, Laura
    Haladyj, Ewa
    Meroni, Pier L.
    Gerosa, Maria
    Alijotas-Reig, Jaume
    Tenti, Sara
    Mayer-Pickel, Karoline
    Simchen, Michal J.
    Bertero, Maria T.
    De Carolis, Sara
    Ramoni, Veronique
    Mekinian, Arsene
    Grandone, Elvira
    Maina, Aldo
    Serrano, Fatima
    Pengo, Vittorio
    Khamashta, Munther A.
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (04) : 639 - 646
  • [22] The risk of cardiac events among patients with systemic lupus erythematosus: comment on the article by Costenbader et al
    Jolly, M
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (03): : 476 - 476
  • [23] Risk factors of atherosclerosis in patients with spondylarthropathies: comment on the article by Gonzalez-Juanatey et al - Reply
    Gonzalez-Gay, Miguel A.
    Gonzalez-Juanatey, Carlos
    Martin, Javier
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (03): : 455 - 456
  • [24] Clinical efficacy and management of primary antifungal prophylaxis with posaconazole in high-risk haematology patients
    Sanchez-Ortega, I.
    Cuesta, I.
    Patino, B.
    Parody, R.
    Arnan, M.
    Fernandez de Sevilla, A.
    Gudiol, C.
    Ayats, J.
    Cuenca-Estrella, M.
    Duarte, R. F.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S318 - S319
  • [25] Limitations in Assessing Cardiovascular Risk of Febuxostat in Patients With Gout and Cardiovascular Morbidities: Comment on the Article by Choi et al
    Abeles, Aryeh M.
    Pillinger, Michael H.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (06) : 1023 - 1024
  • [26] Improving the care of patients with rheumatic diseases who have cardiovascular risk: comment on the article by Gossec et al
    Kreitenberg, Adam J.
    Quismorio, Francisco P., Jr.
    Hsieh, Eric P.
    Ben-Ari, Ron
    Panush, Richard S.
    ARTHRITIS CARE & RESEARCH, 2013, 65 (09) : 1548 - 1549
  • [27] Letter by Scorza et al Regarding Article "High-Risk Human Papillomavirus Infection and the Risk of Cardiovascular Disease in Korean Women"
    Scorza, Fulvio A.
    Fonseca, Marcelo C. M.
    Finsterer, Josef
    Girao, Manoel J. B. C.
    CIRCULATION RESEARCH, 2019, 125 (03) : E13 - E14
  • [28] Comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients," by Garbino et al.
    van Saene, HKF
    Silvestri, L
    Petros, A
    Viviani, M
    de la Cal, MA
    Zandstra, DF
    INTENSIVE CARE MEDICINE, 2003, 29 (07) : 1192 - 1193
  • [29] Comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients," by Garbino et al.
    H. K. F. van Saene
    L. Silvestri
    A. Petros
    M. Viviani
    M. A. de la Cal
    D. F. Zandstra
    Intensive Care Medicine, 2003, 29 : 1192 - 1193
  • [30] Monoclonal antibody immunospecific platelet assay in patients with lupus anticoagulant and prolonged bleeding time:: comment on the article by Urbanus et al
    Schleinitz, N
    Camoin, L
    Bernit, E
    Reviron, D
    Veit, V
    Harlé, JR
    ARTHRITIS AND RHEUMATISM, 2005, 52 (06): : 1949 - 1949
12345